The Taiwan agent rule
Foreign manufacturers file through a Taiwan agent — the official face to the TFDA, with post-market duties.
Free field guide · PDF
The Taiwan agent rule, QSD timelines, and the predicate-device shortcut — with the 5-year licence reality.
Sourced from TFDA 2026 registration guidance and practice.
Enter your work email and we'll send the PDF straight to your inbox.
What's inside
Every figure in this guide traces to a named source — TFDA 2026 registration guidance and practice.
Foreign manufacturers file through a Taiwan agent — the official face to the TFDA, with post-market duties.
QSD review takes 6–8 months and runs concurrently with the device application — with an expedited TCP III pathway.
Acceptable predicates mean quicker review, lower fees, and reference-market exemptions from local clinical data.
This guide is market-access intelligence, not regulatory or legal advice. TFDA timelines, fees, and QSD requirements are product-specific — professional review is required before business use.
Market Access Strategy Session
A Market Access Strategy Session maps your TFDA route — agent selection, QSD sequencing, and the predicate-device plan.
Professional review is required before business use.
Back to ghmap.io Questions? Talk to our team